References
- Dromigny JA, Nabeth P, Perrier-Gros-Claude JD. Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal. Int J Antimicrob Agents 2002; 20: 339–47
- Dromigny JA, Ndoye B, Macondo EA, Nabeth P, Siby T, Perrier-Gros-Claude JD. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Dakar, Senegal: a multicentre study. Diagn Microbiol Infect Dis 2003; 47: 595–600
- Arzouni JP, Bouilloux JP, de Moüy D, Fleutiaux S, Galinier J, Gayon A, et al. Les infections urinaires chez la femme de 15 à 65 ans en pratique de ville : surveillance de la sensibilité de Escherichia coli à la fosfomycine trométamol en fonction des antécédents. Méd et Mal Infect 2000; 30: 699–702
- CA-SFM Comité de l'Antibiogramme de la Société Française de Microbiologie: Communiqué 2004 (Edition de Janvier 2004). Available from: URL: http://www.sfm.asso.fr/
- Daza R, Gutierrez J, Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 2001; 18: 211–5
- Goossens H, Sprenger MJW. Community acquired infections and bacterial resistance. Br Med J 1998; 317: 654–7
- Lobel B. Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories. Int J Antimicrob Agents 2003; 22(Suppl 2)85–7
- Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51: 69–76
- Fuchs PC, Barry AL, Brown SD. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from 10 North American medical centres by 3 methods. J Antimicrob Chemother 1999; 43: 137–40